Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Tau pathology as the key to understanding Alzheimer’s disease

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …
Feature
White paper
abbvie_uk_france

Abbvie names new General Managers for UK and France

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, appointment

Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, …
Appointment
aedes_aegypti_mosquito

Research provides clues about Zika virus damage to foetal brains

June 2, 2017 Research and Development India, Zika, Zika virus

The Zika virus has been documented since 1947 and was first discovered to have infected a human in 1952. The …
News
sara_rajeswaran_v2

ABPI appoints new Executive Director of Government Affairs

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI

The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …
Appointment
astrazeneca_sign_sky

AZ’s Lynparza improves survival and maintains quality of life against ovarian cancer

June 2, 2017 Medical Communications, Research and Development AstraZeneca, lynparza

New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …
News
A example of a myelinated neuron

Old antibiotic offers potential cost-effective MS treatment

June 2, 2017 Medical Communications, Research and Development Myelin, multiple sclerosis

The cost of treatment for multiple sclerosis varies wildly, in the UK treatment can cost £56,000 per year while in …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and the past week was populated with a host of riveting news and features from the life …
News

Clinical Trial Success: How Relationships Are Key

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros

Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …
Feature
White paper
hoffman

Silence Therapeutics instate new COO

June 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics

Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …
Appointment

Europe vs USA: New drug approvals

June 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs

Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …
Feature
White paper
640px-palace_of_westminster_at_night

What the life sciences industry wants from the next UK government

June 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences

The stakes are high as the UK general election draws ever closer, and the industry has come out in force …
Feature
3117187373_19549d5407_z

New method discovered to target chronic pain

June 1, 2017 Research and Development opioid, painkillers

Chronic pain is notoriously difficult to treat and can lead some people to take painkillers of increasing strength to combat …
News
european_commission_web

New biosimilar guidelines launched in the EU

June 1, 2017 Medical Communications, Research and Development, Sales and Marketing EMA, biosimilars

A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for …
News

Navigating the challenges of health technology assessment

May 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …
Feature
Case study
student_writing

NLS Pharma reveals data on different kind of ADHD treatment

May 31, 2017 Research and Development NLS Pharma, mazindol

Most treatments for ADHD are stimulants, while the two most common treatments Adderall and Ritalin contain amphetamines. Due to the …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026